RxDoctor Payments Data

Sudhir Rao, MD

Pain Medicine · Mount Airy, MDNPI 1629103759

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $22,516 of the $25,430 with a category attached, or 88.5%. 40 manufacturers reported payments, led by Medtronic at 40.6% of the total. Among pain medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,430in general payments, 2019–2025

Across 655 payments — averaging $38.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$10K
  • Abbott$7K
  • Nevro Corp.$1K
  • Boston Scientific$992
  • Spinal Simplicity, LLC$885
  • Globus Medical$705
  • plus $4K from 34 others

What the payments were for

  • Travel & lodging$2,87611%
  • Food & beverage$22,51689%
  • Education$370%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,430 in reported general payments places this provider in the 90th percentile of 144 pain medicine providers in Maryland.

See all pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$953,533
Medicare patients
1,389
Services billed
29,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate91$56,144
OxycontinOxycodone Hcl49$38,834
BelbucaBuprenorphine Hcl39$27,439
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen484$13,157
Fentanyl81$12,675
MovantikNaloxegol Oxalate29$11,641
Lidocaine48$7,702
Naloxone Hcl80$7,061
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen237$4,672
Oxycodone Hcl232$3,666
Morphine Sulfate ErMorphine Sulfate148$3,647
Pregabalin179$2,998
Buprenorphine13$2,392
Gabapentin171$2,051
Tramadol Hcl ErTramadol Hcl30$1,527

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$625$83,583130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 144 pain medicine providers in Maryland.

Other pain medicine in Mount Airy

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →